Dark | Light
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

# ![@med__twi Avatar](https://lunarcrush.com/gi/w:26/cr:twitter::2522249316.png) @med__twi El sordo

El sordo posts on X about $mrkde, $gsk the most. They currently have XXX followers and X posts still getting attention that total X engagements in the last XX hours.

### Engagements: X [#](/creator/twitter::2522249316/interactions)
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::2522249316/c:line/m:interactions.svg)

- X Week XX -XX%
- X Month XXXXX -XX%
- X Months XXXXXX -XX%
- X Year XXXXXX +51%

### Mentions: X [#](/creator/twitter::2522249316/posts_active)
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::2522249316/c:line/m:posts_active.svg)

- X Week X -XX%
- X Month X no change
- X Months XX -XX%
- X Year XX +55%

### Followers: XXX [#](/creator/twitter::2522249316/followers)
![Followers Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::2522249316/c:line/m:followers.svg)

- X Week XXX no change
- X Month XXX -XXXX%
- X Months XXX +9%
- X Year XXX +11%

### CreatorRank: undefined [#](/creator/twitter::2522249316/influencer_rank)
![CreatorRank Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::2522249316/c:line/m:influencer_rank.svg)

### Social Influence [#](/creator/twitter::2522249316/influence)
---

**Social category influence**
[stocks](/list/stocks)  XX%

**Social topic influence**
[$mrkde](/topic/$mrkde) 50%, [$gsk](/topic/$gsk) XX%

**Top accounts mentioned or mentioned by**
[@jn66039675](/creator/undefined)

**Top assets mentioned**
[GSK plc (GSK)](/topic/$gsk)
### Top Social Posts [#](/creator/twitter::2522249316/posts)
---
Top posts by engagements in the last XX hours

"Xevinapant with worse () EFS and PFS vs. placebo in phase X trial readout. Inhibitors of apoptosis protein inhibitors obviously not working as intended. Also confirms how hard it is to develop new chemo/RT combinations. $MRK.DE #MerckKGaA"  
[X Link](https://x.com/med__twi/status/1966952678518673568) [@med__twi](/creator/x/med__twi) 2025-09-13T19:50Z XXX followers, XXX engagements


"@Jn66039675 DNA damage as monotherapy documented in several models $GSK follows both approaches In theory could be arguments for combo with immunoTx or with DNA-directed drugs. However monotherapy activity always more promising IMO"  
[X Link](https://x.com/med__twi/status/1977683445343244659) [@med__twi](/creator/x/med__twi) 2025-10-13T10:30Z XXX followers, XXX engagements

[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

@med__twi Avatar @med__twi El sordo

El sordo posts on X about $mrkde, $gsk the most. They currently have XXX followers and X posts still getting attention that total X engagements in the last XX hours.

Engagements: X #

Engagements Line Chart

  • X Week XX -XX%
  • X Month XXXXX -XX%
  • X Months XXXXXX -XX%
  • X Year XXXXXX +51%

Mentions: X #

Mentions Line Chart

  • X Week X -XX%
  • X Month X no change
  • X Months XX -XX%
  • X Year XX +55%

Followers: XXX #

Followers Line Chart

  • X Week XXX no change
  • X Month XXX -XXXX%
  • X Months XXX +9%
  • X Year XXX +11%

CreatorRank: undefined #

CreatorRank Line Chart

Social Influence #


Social category influence stocks XX%

Social topic influence $mrkde 50%, $gsk XX%

Top accounts mentioned or mentioned by @jn66039675

Top assets mentioned GSK plc (GSK)

Top Social Posts #


Top posts by engagements in the last XX hours

"Xevinapant with worse () EFS and PFS vs. placebo in phase X trial readout. Inhibitors of apoptosis protein inhibitors obviously not working as intended. Also confirms how hard it is to develop new chemo/RT combinations. $MRK.DE #MerckKGaA"
X Link @med__twi 2025-09-13T19:50Z XXX followers, XXX engagements

"@Jn66039675 DNA damage as monotherapy documented in several models $GSK follows both approaches In theory could be arguments for combo with immunoTx or with DNA-directed drugs. However monotherapy activity always more promising IMO"
X Link @med__twi 2025-10-13T10:30Z XXX followers, XXX engagements

creator/x::med__twi
/creator/x::med__twi